Emine Vezir

Emine Vezir

Auto-generated profile, based on publicly available information

Emine Vezir

Department of Pediatrics, Division of Allergy and Clinical Immunology, University of Health Sciences, Ankara Training and Research Hospital, Ankara, Türkiye

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in Allergy and Asthma Proceedings
Verified
Journal Article
Closed access
EVEmine Vezir
Emine Vezir
MHMina Hizal
Mina Hizal
BYBurcu Cura Yayla
Burcu Cura Yayla
KAKubra Aykac
Kubra Aykac
AYArzu Yilmaz
Arzu Yilmaz
MCMehmet Ceyhan
Mehmet Ceyhan
Background:There are conflicting data with regard to the impact of respiratory and allergic comorbidities on the course of novel coronavirus disease 2019 (COVID-19) in children.Objective:This study aimed to investigate the relationship between allergic diseases and COVID-19 severity in pediatric patients.Methods:Seventy-five pediatric patients with COVID-19 were classified according to clinical severity and evaluated in the allergy/immunology and pulmonology departments 1 to 3 months after the infection resolved. Blood was collected from the patients for a complete blood cell count and assessment of immunoglobulin and total immunoglobulin E (IgE) levels, and skin-prick tests and spirometry tests were performed.Results:A total of 75 patients ages 5‐18 years were evaluated. COVID-19 was asymptomatic/mild in 44 patients and moderate/severe/critical in 31 patients. Based on allergy evaluation, allergic rhinitis was diagnosed in 19 patients (25.3%), asthma in 10 patients (13%), and atopic dermatitis in 3 patients (4%). Aeroallergen sensitivity was detected in 26 patients (34.7%). COVID-19 infection was asymptomatic/mild in 15 patients with allergic rhinitis (78.9%) and in 21 with aeroallergen sensitivity (80.8%) (p = 0.038 and p = 0.005, respectively). There was no difference in severity between the patients with and without asthma (p = 0.550). The median (interquartile range) total IgE level was significantly higher in the asymptomatic/mild group (71.8 [30.7‐211.2]) (p = 0.015). There were no differences in terms of spirometry parameters.Conclusion:Aeroallergen sensitization and allergic rhinitis in children may be associated with a milder course of COVID-19. The knowledge that atopy is associated with less-severe COVID-19 outcomes in children may guide clinical risk classification.

30 October 2019 in The Journal of Infection in Developing Countries
Verified
Journal Article
Open access
PDF file
SVSedat Vezir
Sedat Vezir
FKFiliz Kaya
Filiz Kaya
EVEmine Vezir
Emine Vezir
NKNermin Karaosmanoğlu
Nermin Karaosmanoğlu
AAAli Kudret Adiloğlu
Ali Kudret Adiloğlu
Introduction: Chronic spontaneous urticaria (CSU) which develops without a known stimulation is defined as the occurrence of spontaneous wheals, angioedema or both for longer than six weeks. Infections, autoimmunity, food intolerance and internal parasitic infections are supposed to be underlying causes of CSU. The aim of this study was to evaluate the intestinal parasites in children and adult patients diagnosed as CSU, to determine the frequency of parasites in chronic urticaria, and to compare these patients with healthy demographic control groups. Methodology: Seventy six children and 38 adult patients with CSU were examined in terms of parasitic infections. The patients whom parasites were detected received anti-parasitic therapy and the improvements in CSU symptoms were evaluated. Stool samples were examined with direct microscopic examination (native-lugol), stool concentration and trichrome staining methods. Results: In pediatric patient group, 18.4% (n = 14) of the stool samples were positive for Blastocystis sp., 2.6% (n = 2), Dientamoeba fragilis and 1.3% (n = 1), Giardia duodenalis. In adult patient group, Blastocystis sp. was detected in 18.4% (n = 7) of the stool samples. Anti-parasitic therapy yielded substantial improvement in urticaria symptoms in 57.1% of pediatric and 60.0% of adult patients. Conclusions: Blastocystis sp. and D. fragilis may play a role in chronic urticaria which seriously disrupts the patient's quality of life. Parasitic infections should not be neglected in patients with cutaneous manifestations.

12 December 2019 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
HGHakan Guvenir
Hakan Guvenir
TATugba Arikoglu
Tugba Arikoglu
EVEmine Vezir
Emine Vezir
EMEmine Dibek Mısırlıoğlu
Emine Dibek Mısırlıoğlu
Drug hypersensitivity reactions are clinically heterogenous ranging from mild to severe. Most drug hypersensitivity reactions are accompanied by cutaneous manifestations. Fever, mucous membrane involvement, large blisters, facial oedema, pustulosis and visceral involvement are clinical features that lead to suspicion of severe adverse drug reactions. Severe cutaneous adverse drug reactions (SCARs) include Stevens-Johnson syndrome, toxic epidermal necrolysis, drug rash eosinophilia and systemic symptoms, acute generalized exanthematous pustulosis. Serum sickness like reactions, drug induced vasculitis and generalized bullous fixed drug eruptions are less severe clinical entities. SCARs are uncommon but associated with significant morbidity and mortality. Physician should be aware of specific red flags and danger signs to immediately identify these reactions. Immediate drug withdrawal is mandatory. Early diagnosis and appropriate treatment significantly affect the prognosis of the disease. The purpose of our review is to discuss clinical phenotypes of severe cutaneous drug hypersensitivity reactions.

22 March 2021 in International Archives of Allergy and Immunology
Verified
Journal Article
Closed access
PDF file
EVEmine Vezir
Emine Vezir
ECErsoy Civelek
Ersoy Civelek
EMEmine Dibek Misirlioglu
Emine Dibek Misirlioglu
MTMuge Toyran
Muge Toyran
MCMurat Capanoglu
Murat Capanoglu
CKCan Naci Kocabas
Can Naci Kocabas
Background: Obese asthma is a complex syndrome with certain phenotypes that differ in children and adults. There is no clear evidence regarding the presence of additive or synergistic pathological interaction between obesity and asthma in children. Objectives: Our aim was to demonstrate the interaction of obesity and asthma in children in terms of airway and systemic inflammation by a controlled observational study. Methods: Four groups were formed: asthma obese (AO), asthma nonobese (ANO), non-AO (NAO), nonasthma nonobese (NANO). Spirometry test, fractional exhaled nitric oxide (FeNO) test, skin prick test, serum inflammatory biomarkers (C-reactive protein, C3, C4, adiponectin, leptin, resistin, periostin, YKL-40, Type 1, and Type 2 cytokines) were conducted and evaluated in all participants. Sputum inflammatory cells (sputum eosinophils and neutrophils) were evaluated in patients who could produce induced sputum and obesity-asthma interactions were determined. Results: A total of 153 participants aged 6–18 years were included in the study, including the AO group (n = 46), the ANO group (n = 45), the NAO group (n = 30), and the NANO group (n = 32). IL-4 (p < 0.001), IL-5 (p < 0.001), IL-13 (p < 0.001), resistin (p < 0.001), and YKL-40 (p < 0.001) levels were higher in patients with asthma independent of obesity. The lowest adiponectin level was found in the AO group and obesity-asthma interaction was detected (p < 0.001). Sputum eosinophilia (p < 0.01), sputum neutrophilia (p < 0.01), and FeNO levels (p = 0.07) were higher in asthmatic patients independent of obesity. In the group with paucigranulocytic inflammation, resistin and YKL-40 levels were significantly lower than in the group without paucigranulocytic inflammation (p < 0.01). Conclusion: No interaction was found between obesity and asthma in terms of airway inflammation. Interaction between obesity and asthma was shown in terms of adiponectin level and resistin/adiponectin and leptin/adiponectin ratios. It was found that serum YKL-40 and resistin levels could be associated with airway inflammation.

7 March 2025 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
AMAzize Pınar Metbulut
Azize Pınar Metbulut
IHİdIl Akay Haci
İdIl Akay Haci
DCDemet Can
Demet Can
HBHayrunnisa Bekis Bozkurt
Hayrunnisa Bekis Bozkurt
OCOzlem Cavkaytar
Ozlem Cavkaytar
EMEmine Dibek Mısırlıoğlu
Emine Dibek Mısırlıoğlu

1 November 2025 in Allergologia et Immunopathologia
Verified
Journal Article
Open access
PDF file
YYYuksel Kavas Yildiz
Yuksel Kavas Yildiz
SYSule Buyuk Yaytokgil
Sule Buyuk Yaytokgil
EVEmine Vezir
Emine Vezir
Objective: This study aimed to evaluate the demographic and clinical features of pediatric aeroallergen sensitization and seasonal symptom patterns, focusing on pollen. Materials and methods: This retrospective single-center study included children aged 1–18 years who underwent standardized skin prick testing (SPT) between January 2020 and July 2021. Patients with chronic or immunological disorders other than asthma, allergic rhinitis (AR), and atopic dermatitis (AD) were excluded. Clinical and laboratory data, including symptom profiles, family atopy history, eosinophil counts, and total IgE, were extracted from records. Aeroallergen panels included pollens, house dust mites, molds, and animal dander. Comparisons were performed between monosensitized and polysensitized patients, and between those sensitized to pollen versus house dust mites. Results: Of 2247 children tested, 2017 were eligible, and 500 (24.7%) with clinically relevant sensitization were analyzed (57% male; median age: 12 years, IQR: 8–15). Pollen was the most frequent sensitizer (78.6%), followed by house dust mites (36.6%). Within pollens, Poaceae predominated (98.1%), with Secale as the leading species (88.4%). Seasonal peaks of symptoms in pollen-sensitized patients occurred in May (31.8%), April (29.6%), and June (27%). Polysensitization was observed in 38.8%. AR was the most common diagnosis (83.2%), while asthma and AD were present in 36.4% and 34.0%, respectively. Pollen sensitization was significantly associated with AR (88% vs. 63%, p < 0.01) and sneezing (38% vs. 16%, p < 0.01), whereas house dust mite sensitization was more often linked with skin rashes (25.5% vs. 13%, p = 0.008). Patients with eosinophilia were younger, predominantly male, and more frequently diagnosed with AR (p < 0.001). Conclusions: Pollen, particularly from the Poaceae family, was the predominant aeroallergen, and symptom timing matched seasonal pollen trends. Inclusion of region-specific pollens such as Secale in SPT panels is crucial for accurate sensitization detection and for guiding localized public health strategies.